Excelsior Medical Statistics
Total Valuation
Excelsior Medical has a market cap or net worth of TWD 14.20 billion. The enterprise value is 14.62 billion.
Market Cap | 14.20B |
Enterprise Value | 14.62B |
Important Dates
The next estimated earnings date is Friday, November 8, 2024.
Earnings Date | Nov 8, 2024 |
Ex-Dividend Date | Apr 19, 2024 |
Share Statistics
Excelsior Medical has 163.40 million shares outstanding. The number of shares has decreased by -0.03% in one year.
Shares Outstanding | 163.40M |
Shares Change (YoY) | -0.03% |
Shares Change (QoQ) | -0.15% |
Owned by Insiders (%) | 2.61% |
Owned by Institutions (%) | 1.99% |
Float | 75.14M |
Valuation Ratios
The trailing PE ratio is 18.32.
PE Ratio | 18.32 |
Forward PE | n/a |
PS Ratio | 1.69 |
PB Ratio | 1.64 |
P/FCF Ratio | 27.08 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.99, with an EV/FCF ratio of 27.88.
EV / Earnings | 18.81 |
EV / Sales | 1.74 |
EV / EBITDA | 10.99 |
EV / EBIT | 13.75 |
EV / FCF | 27.88 |
Financial Position
The company has a current ratio of 1.59, with a Debt / Equity ratio of 13.78.
Current Ratio | 1.59 |
Quick Ratio | 1.36 |
Debt / Equity | 13.78 |
Debt / EBITDA | 1.56 |
Debt / FCF | 2.85 |
Interest Coverage | 37.66 |
Financial Efficiency
Return on equity (ROE) is 8.88% and return on invested capital (ROIC) is 3.66%.
Return on Equity (ROE) | 8.88% |
Return on Assets (ROA) | 2.49% |
Return on Capital (ROIC) | 3.66% |
Revenue Per Employee | 60.91M |
Profits Per Employee | 5.63M |
Employee Count | 138 |
Asset Turnover | 0.49 |
Inventory Turnover | 5.90 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +3.46% in the last 52 weeks. The beta is 0.14, so Excelsior Medical's price volatility has been lower than the market average.
Beta (5Y) | 0.14 |
52-Week Price Change | +3.46% |
50-Day Moving Average | 86.01 |
200-Day Moving Average | 86.32 |
Relative Strength Index (RSI) | 47.81 |
Average Volume (20 Days) | 111,504 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Excelsior Medical had revenue of TWD 8.41 billion and earned 777.26 million in profits. Earnings per share was 4.74.
Revenue | 8.41B |
Gross Profit | 1.68B |
Operating Income | 689.79M |
Pretax Income | 1.15B |
Net Income | 777.26M |
EBITDA | 865.12M |
EBIT | 689.79M |
Earnings Per Share (EPS) | 4.74 |
Balance Sheet
The company has 3.27 billion in cash and 1.50 billion in debt, giving a net cash position of 1.78 billion or 10.89 per share.
Cash & Cash Equivalents | 3.27B |
Total Debt | 1.50B |
Net Cash | 1.78B |
Net Cash Per Share | 10.89 |
Equity (Book Value) | 10.85B |
Book Value Per Share | 52.90 |
Working Capital | 3.75B |
Cash Flow
In the last 12 months, operating cash flow was 657.69 million and capital expenditures -133.26 million, giving a free cash flow of 524.44 million.
Operating Cash Flow | 657.69M |
Capital Expenditures | -133.26M |
Free Cash Flow | 524.44M |
FCF Per Share | 3.21 |
Margins
Gross margin is 19.99%, with operating and profit margins of 8.21% and 9.25%.
Gross Margin | 19.99% |
Operating Margin | 8.21% |
Pretax Margin | 13.64% |
Profit Margin | 9.25% |
EBITDA Margin | 10.29% |
EBIT Margin | 8.21% |
FCF Margin | 6.24% |
Dividends & Yields
This stock pays an annual dividend of 3.62, which amounts to a dividend yield of 4.17%.
Dividend Per Share | 3.62 |
Dividend Yield | 4.17% |
Dividend Growth (YoY) | 9.32% |
Years of Dividend Growth | 1 |
Payout Ratio | 145.68% |
Buyback Yield | 0.03% |
Shareholder Yield | 4.20% |
Earnings Yield | 5.46% |
FCF Yield | 3.69% |
Stock Splits
The last stock split was on August 26, 2024. It was a forward split with a ratio of 1.05.
Last Split Date | Aug 26, 2024 |
Split Type | Forward |
Split Ratio | 1.05 |